Adagene (ADAG) Other Accumulated Expenses (2019 - 2025)
Adagene's (ADAG) quarterly Other Accumulated Expenses came in at $10.3 million in Q4 2025, down 21.54% year-on-year from $13.2 million in Q4 2024, and down 21.54% on a QoQ basis from $13.2 million in Q4 2024.
Adagene (ADAG) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Other Accumulated Expenses data on file, last reported at $10.3 million in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses fell 21.54% year-over-year to $10.3 million in Q4 2025; TTM through Dec 2025 was $10.3 million, a 21.54% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, down 21.54% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $10.3 million, down from $13.2 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for ADAG reached as high as $19.3 million in Q4 2022 and fell as low as $143060.0 in Q4 2021.
- Historically, Other Accumulated Expenses has averaged $11.9 million across 5 years, with a median of $13.2 million in 2024.
- Across the five-year window, Other Accumulated Expenses jumped 13407.16% in 2022 and retreated 21.54% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $143060.0 in 2021, then soared by 13407.16% to $19.3 million in 2022, then fell by 13.5% to $16.7 million in 2023, then declined by 21.1% to $13.2 million in 2024, then declined by 21.54% to $10.3 million in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $10.3 million in Q4 2025, $13.2 million in Q4 2024, and $16.7 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.35 Mn |
| Dec 31, 2024 | 13.19 Mn |
| Dec 31, 2023 | 16.71 Mn |
| Dec 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 143,060.00 |
| Dec 31, 2020 | 145,664.00 |
| Dec 31, 2019 | 19,889.00 |